Tegafur–uracil is a safe alternative for the treatment of colorectal cancer in patients with partial dihydropyrimidine dehydrogenase deficiency: a proof of principle

OBJECTIVE: The objective of this study was to evaluate the safety of using tegafur–uracil (UFT) in colorectal cancer patients with partial dihydropyrimidine dehydrogenase (DPD) deficiency. PATIENTS AND METHODS: The study included five colorectal cancer patients who presented with acute toxicity (gra...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Cubero, Daniel I.G., Cruz, Felipe Melo, Santi, Patrícia, Silva, Ismael Dale C.G., del Giglio, Auro
Médium: Artigo
Jazyk:Inglês
Vydáno: SAGE Publications 2012
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3384092/
https://ncbi.nlm.nih.gov/pubmed/22754590
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758834012441049
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky